University of Texas MD Anderson Cancer Center


Standort der Organisation:
Houston, Vereinigte Staaten von Amerika (USA)

Publikationen in Kooperation mit FAU-Wissenschaftern

Go to first page Go to previous page 1 von 4 Go to next page Go to last page
Black, P.C., Goebell, P., Kamat, A.M., Nawroth, R., Seiler, R., Williams, S.B., & Schmitz-Dräger, B.J. (2019). Editorial: Basic research in bladder cancer – refining the tools. 3rd IBCN seminars series1. Urologic Oncology-Seminars and Original Investigations.
Buckley, M.A., Woods, N.T., Tyrer, J.P., Mendoza-Fandino, G., Lawrenson, K., Hazelett, D.J.,... Freedman, M.L. (2019). Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus. Cancer Research, 79(3).
Yang, Y., Wu, L., Shu, X., Lu, Y., Shu, X.-O., Cai, Q.,... Long, J. (2019). Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk. Cancer Research, 79(3).
Yao, J., Garg, A., Chen, D., Capdevila, J., Engstrom, P., Pommier, R.,... Kulke, M.H. (2019). Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials. Endocrine-Related Cancer, 26(4), 391-403.
Boormans, J.L., Zwarthoff, E.C., Black, P.C., Goebell, P., Kamat, A.M., Nawroth, R.,... Schmitz-Dräger, B.J. (2019). New horizons in bladder cancer research. Urologic Oncology-Seminars and Original Investigations.
Williams, S.B., Hudgins, H.K., Ray-Zack, M.D., Chamie, K., Smaldone, M.C., Boorjian, S.A.,... Gore, J.L. (2019). Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer. European Urology Oncology, 2(2), 119-125.
Yao, J.C., Strosberg, J., Fazio, N., Pavel, M.E., Ruszniewski, P., Bergsland, E.,... Singh, S. (2018). Activity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx). In ANNALS OF ONCOLOGY. Munich, DE: OXFORD: OXFORD UNIV PRESS.
Capper, D., Jones, D.T.W., Sill, M., Hovestadt, V., Schrimpf, D., Sturm, D.,... Pfister, S.M. (2018). DNA methylation-based classification of central nervous system tumours. Nature, 555(7697), 469-474.
Black, P.C., Goebell, P., Kamat, A.M., Nawroth, R., & Schmitz-Draeger, B.J. (2018). Editorial: Managing locally advanced bladder cancer. Third International Bladder Cancer Network seminars series. Urologic Oncology-Seminars and Original Investigations, 36(9), 403-404.
Yao, J.C., Yao, J.C., Fazio, N., Li, D., Pavel, M.E., Strosberg, J.,... Singh, S. (2018). ElevatION: NET-201 A Phase II Study to Evaluate the Efficacy and Safety of PDR001 in Patients with Metastatic, Well-Differentiated NET of Pancreatic/GI/Thoracic Origin or Poorly-Differentiated GEP NEC Who Have Progressed on Prior Treatment. (pp. 218-218).
Brabletz, T., Kalluri, R., Nieto, M.A., & Weinberg, R.A. (2018). EMT in cancer. Nature Reviews Cancer, 18(2), 128-134.
El Hallani, S., Udager, A.M., Bell, D., Fonseca, I., Thompson, L.D.R., Assaad, A.,... Chiosea, S. (2018). Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases. American Journal of Surgical Pathology, 42(1), 18-27.
Schäffner, I., Minakaki, G., Khan, M.A., Balta, E.-A., Schlötzer-Schrehardt, U., Schwarz, T.J.,... Lie, D.C. (2018). FoxO Function Is Essential for Maintenance of Autophagic Flux and Neuronal Morphogenesis in Adult Neurogenesis. Neuron, 99(6), 1188-1203.e6.
Pachera, E., Assassi, S., Assassi, S., Salazar, G., Salazar, G., Frank-Bertoncelj, M.,... Distler, O. (2018). LONG NONCODING RNA H19X IS A MASTER REGULATOR OF EXTRACELLULAR MATRIX PRODUCTION IN SYSTEMIC SCLEROSIS. (pp. A10-A11).
Hurvitz, S.A., Martin, M., Symmans, W.F., Jung, K.H., Huang, C.-S., Thompson, A.M.,... Slamon, D. (2018). Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial. Lancet Oncology, 19(1), 115-126.
Sahebi, F., Garderet, L., Kanate, A.S., Eikema, D.J., Knelange, N.S., Alvelo, O.F.,... Hari, P. (2018). Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report. Biology of Blood and Marrow Transplantation.
Fazio, N., Carnaghi, C., Buzzoni, R., Valle, J., Valle, J., Herbst, F.,... Yao, J.C. (2018). Relationship between Metabolic Toxicity and Efficacy of Everolimus in Patients with Neuroendocrine Tumors (NETs): A Pooled Analysis from the Randomized, Phase 3 RADIANT-3 and RADIANT-4 Trials. (pp. 211-211).
Kelemen, L.E., Earp, M., Fridley, B.L., Chenevix-Trench, G., Fasching, P.A., Beckmann, M.,... Berchuck, A. (2018). rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. International Journal of Molecular Sciences, 19(9).
Mathew, N.R., Baumgartner, F., Braun, L., O'Sullivan, D., Thomas, S., Waterhouse, M.,... Zeiser, R. (2018). Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nature Medicine.
Chan, D.L., Yao, J.C., Carnaghi, C., Buzzoni, R., Herbst, F., Herbst, F.,... Singh, S. (2018). Systemic Markers of Inflammation in Neuroendocrine Tumors (NETs) and Outcomes with Everolimus: A Pooled Analysis from the Randomized, Phase 3 RADIANT-3 and RADIANT-4 Trials. (pp. 151-151).

Zuletzt aktualisiert 2016-21-04 um 08:24